Ashwagandha under the microscope: 12-Month safety check for popular herb
NCT ID NCT06244147
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 200 adults aged 18 to 65 who were already taking the herbal supplement KSM-66 ashwagandha as prescribed by their doctor. The main goal was to check for any side effects over a full year, with a focus on liver health. Researchers also looked at whether the supplement helped with stress or other conditions, but this was an observational study, not a treatment trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SF Research Institute
San Francisco, California, 94127, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressurized oxygen boost cord blood transplants?
- New stem cell filter could cut transplant complications in blood cancer patients
- New app guides young cancer survivors through life after treatment
- Light at home may lift brain fog for childhood cancer survivors
- Amish & mennonite volunteers sought to boost medical research
- New drug combo shows promise in early trial for tough blood cancer